| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a26914efc8e9f0082fffc6be728c2fd9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0cd95eb4105b5055e96910c25473cbd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fccdb9c816867fa5614e66383d124f76 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-235
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-235
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-727 |
| filingDate |
2010-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4aa7d18076bf978cc2722836cd97b83a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75d4117b80a1ee832e664b7523a78a2d |
| publicationDate |
2011-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011017810-A1 |
| titleOfInvention |
Combination therapy to treat vascular disorders |
| abstract |
Pharmaceutical compositions and methods for treating vascular disorders comprising the combination of triflusal or a metabolite thereof and a second active agent selected from the group consisting of a GPIIb/IIIa inhibitor, an EDP receptor antagonist, a phosphodiesterase inhibitor and a low molecular weight heparin. The preferred vascular disorder treated is stroke. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2508187-A1 |
| priorityDate |
2009-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |